|
(b)(4).\
date sent: 10/21/2026.\
\
\
an analysis of the product could not be performed since a physical sample was not received for evaluation.\
as part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.\
however, if the product is received at a later date, the investigation will be updated as applicable.\
\
the manufacturing records were reviewed and the manufacturing/packaging criteria were met prior to the release of this lot.\
\
this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.\
\
attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: \
\
\
did the explant take place on (b)(6) 2026?\
what is meant by ¿linx device implanted in the patient was displaced at some point?\".\
did the device migrate? \
upon explant was the device intact/or discontinuous?\
was the device found it the anatomical position upon removal? \
how was the migration of the device diagnosed (chest x-ray, esophageal line at explant)?\
are there images available that shows the migration?\
if yes, please send them to productcomplaint1@its.Jnj.Com.\
did the patient have a hiatal hernia at the time of implant? if yes was this repaired at this time of implant?\
does the patient have a re-occurring hernia now? if yes, did the position of the device change based on the hernia reoccurring?\
will the device be returning for analysis?.
|